Bharat Biotech has around 10 million vaccine doses ready, Dr. Savita Verma told NDTV (file) New Delhi: Covaxin, the coronavirus vaccine from Hyderabad-based Bharat Biotech, has been recommended for “restricted use in emergency situations of public interest” by a government-appointed panel, which presented its findings to the General Controller of …
Read More »Covaxin vaccine: DCGI panel to meet with Bharat Biotech officials shortly | India News
NEW DELHI: The Subject Matter Expert Committee (SEC) of the national drug regulator is likely to hold a meeting with Bharat Biotech on Saturday to consider your Covid-19 vaccine applicant, Covaxin. The committee constituted by the Central Organization for the Control of Medicines Standards on Friday had held that the …
Read More »Emergency approval not recommended for Covaxin; the panel asks for more data
A committee of subject matter experts established by the Comptroller General of Drugs of India (DCGI) to review COVID-19 vaccine proposals, recommended an “interim efficacy analysis for Covaxin.” The vaccine was developed by Bharat Biotech in collaboration with the Indian Council for Medical Research (ICMR). The expert committee asked a …
Read More »The SEC will meet today to authorize the emergency use of COVID vaccines
The third ongoing vaccine, Bharat Biotech’s Covaxin, which is being developed in collaboration with the Indian Council for Medical Research (ICMR), is simultaneously undergoing Phase 3 human trials at 22 sites in India with around 26,000 volunteers. . According to a senior company official, it will be at least 60 …
Read More »Coronavirus | COVID-19 Vaccine Near Approval, India’s General Drug Controller Hints
VG Somani, Comptroller General of Drugs of India (DCGI), in a webinar on Thursday indicated that India was close to approving a COVID-19 vaccine. Mr. Somani was participating in a webinar, organized by the Department of Biotechnology, in which vaccine experts, infectious disease experts and representatives of companies developing vaccines …
Read More »‘We will probably have a very happy new year’: DCGI on the Covid-19 vaccine
New Delhi: India is likely to have a Covid-19 vaccine in the New Year, India’s general drug controller VG Somani hinted on Thursday. Speaking at a webinar, Somani said most importantly, industry and research organizations have stood the test of time. He said that the vaccine candidates got the funding …
Read More »DCGI on the Covid-19 Vaccine: We will probably have a very Happy New Year | India News
NEW DELHI: India is likely to have a Covid-19 vaccine in the new year, India’s general drug controller VG Somani hinted on Thursday. Speaking at a webinar, Somani said most importantly, industry and research organizations have stood the test of time. He said that the vaccine candidates got the funding …
Read More »Oxford Covid Vaccine May Become First To Get Clearance From Indian Regulator For Emergency Use
New Delhi: With preparations underway for a possible vaccine launch in January, India’s drug regulator is looking into the UK, which sources say could give the Oxford COVID-19 vaccine its go-ahead next week, ahead of decide to grant emergency use authorization to the Serum Institute. who is manufacturing the shots …
Read More »Indian Covaxin Vaccine Has Drawn World Attention – ICMR
The Indian Council for Medical Research (ICMR) has said that the Indian vaccine against Covid-19, Covaxin, has attracted global attention. In a tweet, the ICMR said: “India’s indigenous vaccine against covaxin # Covid19, a product of the ICMR-Bharat Biotech collaboration, achieves a remarkable feat. The data generated from India underscores …
Read More »Simulation for the administration of the COVID-19 vaccine to be held in AP, Assam, Gujarat, Punjab
The two-day activity is scheduled for December 28 and 29. A trial for the administration of the COVID-19 vaccine has been planned in four states of the country next week, according to a statement issued by the Union government on Friday. The four states include Andhra Pradesh, Assam, Gujarat, and …
Read More »